Correlation Between Pfizer and Close Brothers
Can any of the company-specific risk be diversified away by investing in both Pfizer and Close Brothers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Close Brothers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Close Brothers Group, you can compare the effects of market volatilities on Pfizer and Close Brothers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Close Brothers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Close Brothers.
Diversification Opportunities for Pfizer and Close Brothers
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Close is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Close Brothers Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Close Brothers Group and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Close Brothers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Close Brothers Group has no effect on the direction of Pfizer i.e., Pfizer and Close Brothers go up and down completely randomly.
Pair Corralation between Pfizer and Close Brothers
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.29 times more return on investment than Close Brothers. However, Pfizer Inc is 3.49 times less risky than Close Brothers. It trades about -0.06 of its potential returns per unit of risk. Close Brothers Group is currently generating about -0.23 per unit of risk. If you would invest 2,787 in Pfizer Inc on September 2, 2024 and sell it today you would lose (166.00) from holding Pfizer Inc or give up 5.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Close Brothers Group
Performance |
| Timeline |
| Pfizer Inc |
| Close Brothers Group |
Pfizer and Close Brothers Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Close Brothers
The main advantage of trading using opposite Pfizer and Close Brothers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Close Brothers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Close Brothers will offset losses from the drop in Close Brothers' long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| Close Brothers vs. Morgan Stanley | Close Brothers vs. Goldman Sachs Group | Close Brothers vs. HUMANA INC | Close Brothers vs. SCOR PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |